首页> 外国专利> TUMESCENT INFILTRATION DRUG DELIVERY OF HIGH SUBCUTANEOUS DRUG CONCENTRATIONS WITH PROLONGED LOCAL AND SYSTEMIC EFFECTS AND MINIMAL LOCAL OR SYSTEMIC TOXICITY

TUMESCENT INFILTRATION DRUG DELIVERY OF HIGH SUBCUTANEOUS DRUG CONCENTRATIONS WITH PROLONGED LOCAL AND SYSTEMIC EFFECTS AND MINIMAL LOCAL OR SYSTEMIC TOXICITY

机译:高局部和全身作用以及最小的局部或全身毒性的高皮下药物浓度的半月型渗透药物输送

摘要

A tumescent composition comprising a drug or a therapeutic agent in a tumescent solution, wherein a tumescent concentration of the drug or therapeutic agent is simultaneously below a threshold for local, subcutaneous tissue toxicity, above a threshold for positive local therapeutic effect, and above a concentration safely achievable by intravenous (IV), intramuscular (IM) or oral (PO) delivery; and the tumescent solution comprises a vasoconstrictor; a pharmaceutically acceptable carrier; and optionally a local anesthetic, wherein the tumescent solution does not comprise an antibiotic.
机译:在肿胀溶液中包含药物或治疗剂的肿胀组合物,其中所述药物或治疗剂的肿胀浓度同时低于局部皮下组织毒性的阈值,高于阳性局部治疗作用的阈值且高于浓度可通过静脉(IV),肌肉(IM)或口服(PO)递送安全地实现;膨胀溶液包括血管收缩剂;药学上可接受的载体;任选地局部麻醉剂,其中肿胀溶液不包含抗生素。

著录项

  • 公开/公告号US2020101012A1

    专利类型

  • 公开/公告日2020-04-02

    原文格式PDF

  • 申请/专利权人 HK TUMESCENT PHARMA CORPORATION;

    申请/专利号US201916700740

  • 发明设计人 JEFFREY ALAN KLEIN;PAYTRA ALAN KLEIN;

    申请日2019-12-02

  • 分类号A61K9;A61K9/08;A61K45/06;A61K31/4164;A61K31/167;A61K31/546;A61K31/522;A61K31/137;A61K47/02;A61K31/52;

  • 国家 US

  • 入库时间 2022-08-21 11:20:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号